Related Experiment Video
Updated: Jan 4, 2026

16:10
A TIRF Microscopy Technique for Real-time, Simultaneous Imaging of the TCR and its Associated Signaling Proteins
Published on: March 22, 2012
24.3K
TCR Ligand Discovery via T-Scan
Zhe Wang1, Genhong Cheng2, Guideng Li1
1Center of Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China; Suzhou Institute of Systems Medicine, Suzhou 215123, China.
Trends in Immunology
|November 9, 2019
Summary
Researchers developed a new screening platform for unbiased T cell receptor (TCR) ligand discovery. This method aids in identifying antigens that activate specific T cell responses.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- T cell receptor (TCR) ligand discovery is essential for understanding T cell-mediated immunity.
- Identifying antigens recognized by specific TCRs is critical for therapeutic and diagnostic applications.
- Current methods for TCR ligand discovery can be limited in scope and efficiency.
Purpose of the Study:
- To describe a novel functional T cell ligand screening platform.
- To enable unbiased discovery of ligands for T cell receptors.
- To facilitate the identification of antigens reactive against orphan TCRs.
Main Methods:
- Development of a high-throughput screening platform utilizing functional T cell assays.
- Application of the platform for unbiased screening of potential TCR ligands.
- Validation of identified ligands for their ability to activate specific T cell responses.
Main Results:
- Successful implementation of a functional T cell ligand screening platform.
- Demonstration of the platform's capability for unbiased TCR ligand discovery.
- Identification of novel antigens reactive against previously uncharacterized TCRs.
Conclusions:
- The described platform offers a powerful tool for advancing TCR ligand discovery.
- This approach can significantly accelerate the identification of T cell antigens.
- The platform holds promise for applications in immunotherapy and diagnostics.

